Ontogeny of androgen receptor expression in spinal nucleus of the bulbocavernosus motoneurons and their target muscles in male mice.

A Comparison of Three Job Engagement Measures: Examining their Factorial and Criterion-Related Validity.

Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer.

Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Parametric model of combination therapy for Non-Hodgkin Lymphoma.

Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.

Dose dependent effects on cell cycle checkpoints and DNA repair by bendamustine.

Prediction and Early Detection of Response by NMR Spectroscopy and Imaging.

Lacrimal gland lymphoma: Role of radiation therapy.